JP2004536041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536041A5 JP2004536041A5 JP2002571531A JP2002571531A JP2004536041A5 JP 2004536041 A5 JP2004536041 A5 JP 2004536041A5 JP 2002571531 A JP2002571531 A JP 2002571531A JP 2002571531 A JP2002571531 A JP 2002571531A JP 2004536041 A5 JP2004536041 A5 JP 2004536041A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- chemical
- analog
- cysteine
- structural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 claims 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 4
- 235000018417 cysteine Nutrition 0.000 claims 4
- 238000010276 construction Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 210000000265 Leukocytes Anatomy 0.000 claims 2
- 210000002865 immune cell Anatomy 0.000 claims 2
- 102000006495 integrins Human genes 0.000 claims 2
- 108010044426 integrins Proteins 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 206010024324 Leukaemias Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 230000003042 antagnostic Effects 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 230000021164 cell adhesion Effects 0.000 claims 1
- 230000012292 cell migration Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20010491A FI114710B (fi) | 2001-03-12 | 2001-03-12 | Leukosyytti-integriinien uusia peptidiligandeja |
| PCT/FI2002/000188 WO2002072618A1 (en) | 2001-03-12 | 2002-03-11 | Novel peptide ligands of leukocyte integrins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536041A JP2004536041A (ja) | 2004-12-02 |
| JP2004536041A5 true JP2004536041A5 (th) | 2005-12-22 |
Family
ID=8560720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002571531A Pending JP2004536041A (ja) | 2001-03-12 | 2002-03-11 | 白血球インテグリンの新規ペプチドリガンド |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7205383B2 (th) |
| EP (1) | EP1373303A1 (th) |
| JP (1) | JP2004536041A (th) |
| KR (1) | KR20030093238A (th) |
| CN (1) | CN1860129A (th) |
| BR (1) | BR0208364A (th) |
| CA (1) | CA2441210A1 (th) |
| CZ (1) | CZ20032632A3 (th) |
| EE (1) | EE200300443A (th) |
| FI (1) | FI114710B (th) |
| HR (1) | HRP20030708A2 (th) |
| HU (1) | HUP0402246A2 (th) |
| IL (1) | IL157831A0 (th) |
| NO (1) | NO20034002L (th) |
| NZ (1) | NZ528044A (th) |
| PL (1) | PL365108A1 (th) |
| RU (1) | RU2003130082A (th) |
| SK (1) | SK12762003A3 (th) |
| WO (1) | WO2002072618A1 (th) |
| YU (1) | YU70903A (th) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI115035B (fi) * | 2003-05-02 | 2005-02-28 | Ctt Cancer Targeting Tech Oy | In vivo -kuvantaminen käyttäen peptidijohdannaisia |
| CN103458911B (zh) * | 2011-02-11 | 2016-02-24 | 密歇根大学董事会 | 肽组合物和用于治疗患者的方法 |
| AU2012291972B2 (en) * | 2011-08-04 | 2017-03-09 | Pharis Biotec Gmbh | Process for preparing human relaxin-2 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877275A (en) * | 1988-06-28 | 1999-03-02 | The General Hospital Corporation | Controlling cellular immune/inflammatory responses with β2 integrins |
| GB9213077D0 (en) * | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
| US5840485A (en) * | 1993-05-27 | 1998-11-24 | Selectide Corporation | Topologically segregated, encoded solid phase libraries |
| US5821329A (en) * | 1996-06-06 | 1998-10-13 | Tanabe Seiyaku Co., Ltd. | Cyclic peptide inhibitors of β1 and β2 integrin-mediated adhesion |
-
2001
- 2001-03-12 FI FI20010491A patent/FI114710B/fi active
-
2002
- 2002-03-11 BR BR0208364-7A patent/BR0208364A/pt not_active IP Right Cessation
- 2002-03-11 KR KR10-2003-7011968A patent/KR20030093238A/ko not_active Application Discontinuation
- 2002-03-11 CA CA002441210A patent/CA2441210A1/en not_active Abandoned
- 2002-03-11 PL PL02365108A patent/PL365108A1/xx not_active Application Discontinuation
- 2002-03-11 HU HU0402246A patent/HUP0402246A2/hu unknown
- 2002-03-11 IL IL15783102A patent/IL157831A0/xx unknown
- 2002-03-11 WO PCT/FI2002/000188 patent/WO2002072618A1/en not_active Application Discontinuation
- 2002-03-11 JP JP2002571531A patent/JP2004536041A/ja active Pending
- 2002-03-11 NZ NZ528044A patent/NZ528044A/en unknown
- 2002-03-11 EP EP02706788A patent/EP1373303A1/en not_active Withdrawn
- 2002-03-11 EE EEP200300443A patent/EE200300443A/xx unknown
- 2002-03-11 CZ CZ20032632A patent/CZ20032632A3/cs unknown
- 2002-03-11 CN CNA028065123A patent/CN1860129A/zh active Pending
- 2002-03-11 SK SK1276-2003A patent/SK12762003A3/sk not_active Application Discontinuation
- 2002-03-11 US US10/469,131 patent/US7205383B2/en not_active Expired - Fee Related
- 2002-03-11 RU RU2003130082/13A patent/RU2003130082A/ru not_active Application Discontinuation
- 2002-03-11 YU YU70903A patent/YU70903A/sh unknown
-
2003
- 2003-09-05 HR HR20030708A patent/HRP20030708A2/xx not_active Application Discontinuation
- 2003-09-10 NO NO20034002A patent/NO20034002L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005516885A5 (th) | ||
| UY27127A1 (es) | Derivados de la urea como antagonistas de integrin alfa-4 | |
| KR101513737B1 (ko) | 합성 펩타이드 아마이드와 그의 다이머 | |
| JP2004115529A5 (th) | ||
| WO2001021159A3 (en) | Pharmaceutical composition of nateglinide and another antidiabetcagent | |
| BR0009964A (pt) | Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial | |
| AU2002328494B2 (en) | Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients | |
| JP2007529532A5 (th) | ||
| NZ514661A (en) | alpha-substituted carboxylic acid derivatives and their use as therapeutic agents in pharmaceutical compositions | |
| HUP0003386A2 (hu) | CRF antagonisták alkalmazása depresszió, kardiovaszkuláris betegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| NZ594055A (en) | New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein | |
| JP2005527547A5 (th) | ||
| US5231082A (en) | Cyclic peptide with anti-metastasis activity | |
| JP2005501010A5 (th) | ||
| DE602007002553D1 (de) | Ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung | |
| IL163951A0 (en) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| ATE393631T1 (de) | Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen | |
| WO2005066207A8 (en) | Glucagon-like peptide-1 analogs with long duration of action | |
| RU2001132140A (ru) | Рекомбинантный рецептор коллагена на тромбоцитах гликопротеин VI и его применение в фармацевтике | |
| JP2004536041A5 (th) | ||
| ES2186576A1 (es) | Acido 2-hidroxioleico para utilizar como medicamento. | |
| JP2008518622A5 (th) | ||
| HRP20080255A2 (en) | Use of cicletanine and other furopyridines for treatment of systolic predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension | |
| WO2002004487A3 (de) | Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen | |
| RU2003130082A (ru) | Новые пептидные лиганды лейкоцитарных интегринов |